Volume control and blood pressure management in patients undergoing quotidian hemodialysis

American Journal of Kidney Diseases

Volumn 42, Issue 1 SUPPL. 1, 2003, Pages

  Nesrallah, Gihad ^b   Suri, Rita ^b   Moist, Louise ^b   Kortas, Claude ^b   Lindsay, Robert M ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

Blood pressure; Daily hemodialysis (HD); Extracellular fluid volume (ECFV); Homocysteine; Interdialytic weight gain; Nocturnal hemodialysis (HD); Quotidian hemodialysis (HD)

Indexed keywords

ANTIHYPERTENSIVE AGENT; HOMOCYSTEINE;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; MORTALITY; TABLET; TREATMENT OUTCOME; UNITED KINGDOM; WEIGHT GAIN;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; APPOINTMENTS AND SCHEDULES; BLOOD PRESSURE; EXTRACELLULAR FLUID; FEMALE; FOLLOW-UP STUDIES; HEMODIALYSIS, HOME; HOMOCYSTEINE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ONTARIO; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0037665414     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. US Renal Data System: USRDS 2000 Annual Data Report, Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2000
2. Canadian Organ Renal Replacement Register: Canadian Institute for Health Information Annual Report, 1997: Dialysis and Renal Transplantation, vol 1. Toronto, Canada, Canadian Institute for Health Information, 1997
3. Mittal SK, Kowalski E, Trenkle J, et al: Prevalence of hypertension in a hemodialysis population. Clin Nephrol 51:77-82, 1999
4. London G: Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transplant 16: 3-6, 2001
5. Buoncristiani U, Fagugli R, Ciao G, et al: Left ventricular hypertrophy in daily dialysis. Miner Electrolyte Metab 25:90-94, 1999
6. Lindsay RM, Leitch R, Heidenheim AP, Kortas C: The London Daily/Nocturnal Hemodialysis Study - Study design, morbidity, and mortality results. Am J Kidney Dis 42:S5-S12, 2003 (suppl 1)
7. Talluri A, Maggia G: Bioimpedance analysis (BIA) in hemodialysis: Technical aspects. Int J Artif Organs 18:687-692, 1995
8. Traeger J, Galland R, Arkouche W, Delawari E, Fouque D: Short daily hemodialysis: A four-year experience. Dial Transplant 30:76-86, 2001
9. Williams A, O'Sullivan D, McCarthy J: Slow nocturnal and short daily hemodialysis: A comparison. Semin Dial 12:431-439, 1999
10. Fagugli RM, Buoncristiani U, Ciao G: Anemia and blood pressure correction obtained by daily hemodialysis induce a reduction of left ventricular hypertrophy in dialysed patients. Int J Artif Organs 21:429-431, 1998
11. Salem MM: Pathophysiology of hypertension in renal failure. Semin Nephrol 22:17-26, 2002
12. Nesrallah G, Bergman A, Heidenheim AP, Leitch R, Lindsay RM: Short hours daily and slow nocturnal hemodialysis improve blood pressure control: Are the mechanisms the same? J Am Soc Nephrol 12:273A, 2001 (abstr)
13. Buoncristiani U: Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 13:148-151, 1998
14. Lockridge R Jr, Anderson H, Coffey L, et al: Nightly home hemodialysis in Lynchburg, Virginia: Economic and logistic considerations. Semin Dial 12:440-447, 1999
15. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996
16. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61:2235-2239, 2002
17. Mallamaci F, Zoccali C, Tripepi G, et al: Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61:609-614, 2002